摘要 |
<p>Compositions and methods for treating or preventing a hematologic malignancy, such as AML, using an antι-alpha4 antibody in combination with chemotherapy agents in a therapeutically effective amount The method includes administering to the patient a therapeutically effective amount of a composition containing an antagonist of an interaction between an integnn with an alpha4 subunit (VLA-4) and a ligand for this integnn (VCAM-1).</p> |